• 2024 Residency Match Stats and Predictions

  • Jul 16 2024
  • Length: 14 mins
  • Podcast

2024 Residency Match Stats and Predictions

  • Summary

  • This episode is all about our breakdown and opinions of the 2024 ASHP residency match statistics. Match statistics have stayed relatively the same from 2023 with little difference in number of applicants and match rate. This could mean good things! Your chance of matching to a program should stay relatively the same this year meaning an 80-90% chance to match to a program as long as you get an interview with one program.

    This is our last episode of the preparation podcast episode. We will continue to be the post-graduate pharmacist, but we are making the transition to a podcast for current graduates and current practicing post-graduate pharmacist. Stay tuned for updates and insights into our new series that we hope to release by the end of 2024.

    This episode's take-aways:

    1. Match rates have leveled off at around 82% match rates for those participating in the match.
    2. Higher number of early commitments to PGY2 programs from current PGY1 residents

    Check out our website and sign-up to join the SASO (separate and stand out) squad. Check out our blog. If you like the show, support us by telling your friends or colleagues about it. You can also support us by clicking the coffee button on the website and buying us a cup of coffee or getting yourself some of our premium merch.


    Follow us on twitter @PGPharmacist or on Facebook, Instagram, or LinkedIn @ThePostGraduatePharmacist. What questions did we not answer? What did you think of the show?


    Music | "Sweet" by LiQWYD

    Watch: https://youtu.be/eIYlaVPdNYM

    License: https://www.liqwydmusic.com/how-to-use

    Download/Stream: https://hypeddit.com/link/un7fp7

    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about 2024 Residency Match Stats and Predictions

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.